Steven Cohen’s Cytek Biosciences CTKB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$135K Sell
22,593
-399,768
-95% -$1.9M ﹤0.01% 3593
2026
Q2
$1.87M Buy
+422,361
New +$1.8M ﹤0.01% 2433
2026
Q1
– Sell
-114,256
Closed -$577K – 3896
2025
Q4
$577K Sell
114,256
-73,362
-39% -$341K ﹤0.01% 3169
2025
Q3
$651K Buy
+187,618
New +$704K ﹤0.01% 1831
2025
Q2
– Sell
-17,496
Closed -$70.2K – 2262
2025
Q1
$70.2K Sell
17,496
-371,863
-96% -$1.93M ﹤0.01% 1941
2024
Q4
$2.53M Buy
+389,359
New +$2.32M 0.01% 1163
2023
Q1
– Sell
-812,662
Closed -$8.3M – 2289
2022
Q4
$8.3M Buy
812,662
+139,175
+21% +$1.87M 0.03% 612
2022
Q3
$9.9M Sell
673,487
-862,592
-56% -$11.2M 0.04% 508
2022
Q2
$16.5M Buy
1,536,079
+905,079
+143% +$9.01M 0.07% 366
2022
Q1
$6.8M Buy
+631,000
New +$8.52M 0.03% 615

Other funds holding CTKB

Steven Cohen's CTKB Position: Q3 2026 in Review

Steven Cohen reduced its Cytek Biosciences (CTKB) stake by 95% in Q3 2026, selling an estimated $1.9M and leaving 22,593 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #3593.

Steven Cohen first reported a position in CTKB in Q1 2022 and has held it in 10 quarters since. The position peaked at $16.5M in Q2 2022. 152 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.

  • Steven Cohen held 22,593 shares of Cytek Biosciences worth $135K as of Q3 2026.
  • Steven Cohen sold 399,768 Cytek Biosciences shares in Q3 2026, an estimated $1.9M.
  • Cytek Biosciences made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3593 holding.
  • Steven Cohen first reported a position in Cytek Biosciences in Q1 2022 and has held it in 10 quarters since.
  • Steven Cohen's Cytek Biosciences position peaked at $16.5M in Q2 2022.
  • 152 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.